These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 33089772)

  • 1. Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020.
    Chan PKS; Lui G; Hachim A; Ko RLW; Boon SS; Li T; Kavian N; Luk F; Chen Z; Yau EM; Chan KH; Tsang CH; Cheng SMS; Chu DKW; Perera RAPM; Ho WCS; Yeung ACM; Chow C; Poon LLM; Valkenburg SA; Hui DSC; Peiris M
    Emerg Infect Dis; 2020 Dec; 26(12):3076-3078. PubMed ID: 33089772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong.
    Miot EF; Worthington BM; Ng KH; de Lataillade LG; Pierce MP; Liao Y; Ko R; Shum MH; Cheung WY; Holmes EC; Leung KS; Zhu H; Poon LL; Peiris MJ; Guan Y; Leung GM; Wu JT; Lam TT
    Emerg Infect Dis; 2022 Feb; 28(2):467-470. PubMed ID: 35076003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.
    Awada H; Nassereldine H; Hajj Ali A
    J Med Case Rep; 2021 Jul; 15(1):382. PubMed ID: 34271967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
    Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.
    Fintelman-Rodrigues N; da Silva APD; Dos Santos MC; Saraiva FB; Ferreira MA; Gesto J; Rodrigues DAS; Vale AM; de Azevedo IG; Soares VC; Jiang H; Tan H; Tschoeke DA; Sacramento CQ; Bozza FA; Morel CM; Bozza PT; Souza TML
    Emerg Infect Dis; 2021 May; 27(5):1446-1453. PubMed ID: 33797393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
    Markmann AJ; Giallourou N; Bhowmik DR; Hou YJ; Lerner A; Martinez DR; Premkumar L; Root H; van Duin D; Napravnik S; Graham SD; Guerra Q; Raut R; Petropoulos CJ; Wrin T; Cornaby C; Schmitz J; Kuruc J; Weiss S; Park Y; Baric R; de Silva AM; Margolis DM; Bartelt LA
    mSphere; 2021 Aug; 6(4):e0027521. PubMed ID: 34431693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea.
    Go YY; Carrai M; Choi YR; Brackman CJ; Tam KWS; Law PYT; Woodhouse F; Gray J; Kim JH; Park J; Jeon CW; Jang H; Magouras I; Decaro N; Cheng SMS; Peiris M; Beatty JA; Barrs VR
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.
    Klein J; Brito AF; Trubin P; Lu P; Wong P; Alpert T; Peña-Hernández MA; Haynes W; Kamath K; Liu F; Vogels CBF; Fauver JR; Lucas C; Oh J; Mao T; Silva J; Wyllie AL; Muenker MC; Casanovas-Massana A; Moore AJ; Petrone ME; Kalinich CC; Dela Cruz C; Farhadian S; Ring A; Shon J; Ko AI; Grubaugh ND; Israelow B; Iwasaki A; Azar MM;
    J Infect Dis; 2022 Feb; 225(3):374-384. PubMed ID: 34718647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China.
    Barrs VR; Peiris M; Tam KWS; Law PYT; Brackman CJ; To EMW; Yu VYT; Chu DKW; Perera RAPM; Sit THC
    Emerg Infect Dis; 2020 Dec; 26(12):3071-3074. PubMed ID: 32938527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong.
    Kwok KO; Li KK; Chan HHH; Yi YY; Tang A; Wei WI; Wong SYS
    Emerg Infect Dis; 2020 Jul; 26(7):1575-1579. PubMed ID: 32298227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
    Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
    Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021.
    Chu DKW; Gu H; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Tsang DNC; Peiris M; Poon LLM
    Emerg Infect Dis; 2021 Aug; 27(8):2230-2232. PubMed ID: 34004137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021.
    Gu H; Krishnan P; Ng DYM; Chang LDJ; Liu GYZ; Cheng SSM; Hui MMY; Fan MCY; Wan JHL; Lau LHK; Cowling BJ; Peiris M; Poon LLM
    Emerg Infect Dis; 2022 Feb; 28(2):460-462. PubMed ID: 34860154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinfection With SARS-CoV-2: Implications for Vaccines.
    Cohen JI; Burbelo PD
    Clin Infect Dis; 2021 Dec; 73(11):e4223-e4228. PubMed ID: 33338197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Choe PG; Kang CK; Suh HJ; Jung J; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Park WB; Oh MD
    Emerg Infect Dis; 2021 Jan; 27(1):327-9. PubMed ID: 33050983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Community Vulnerability over 3 Waves of COVID-19 Pandemic, Hong Kong, China.
    Liao Q; Dong M; Yuan J; Fielding R; Cowling BJ; Wong IOL; Lam WWT
    Emerg Infect Dis; 2021 Jul; 27(7):1935-1939. PubMed ID: 34152957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.